History
A leading pharmaceutical company operating since 1950, setting a high standard of quality, reliability, and medical innovation.
1950
Taro manufacturing facility established in Israel for production of finished pharmaceutical products
1961
Production of active pharmaceutical ingredients (API) for Taro products in Israel
1984
Acquisition of creams and ointments manufacturing facility in Canada
1988
Entry into the American market
2003
Establishment of branded products division
2006
Launch of advanced manufacturing facilities at Taro Israel
2010
2010 – Taro was acquired by Sun Pharmaceuticals
2012
Over $1 billion gross sales (IMS 2012)
2012
Company IPO on NYSE
2016
T Taro from Sun Pharma Group – the leading generic dermatology company in the USA
2022
Taro from Sun Pharma Group completes acquisition of Alkemi
2024
2024 – On June 24, 2024, Taro became a private company and a wholly-owned subsidiary of Sun Pharma, and its shares ceased trading on the New York Stock Exchange.
Contact Us
(A Sun Pharma Company)
14 Hakitor Street, PO Box 10347
Haifa Bay, 2624761, Israel
Telephone: +972-4-8475700
Fax: +972-4-8727165